How an ALK+ Non-Small Cell Lung Cancer Patient Became an Advocate
Gina Hollenbeck never considered that she could have lung cancer. She did not fall into any categories that would put her at a higher risk
A Fresh Chapter
A Fresh Chapter
A Fresh Chapter is a non-profit organization that facilitates life-changing volunteer and leadership experiences to empower people impacted by cancer. AFC programs blend volunteerism and meaningful travel to connect cancer patients and caregivers around the globe, and focus on healing the often over-looked emotional scars left by cancer. AFC’s perspective-shifting journeys to places like India, Peru and Kenya help participants reframe adversity and discover a new perspective and purpose in their lives.
Condition Awareness & Advocacy
Here is a list of conditions this partner raises awareness and advocacy for:
- Cancer
Patient Worthy Posts on Cancer
EMA Recommends ALUNBRIG for the Treatment of Non-Small Cell Lung Cancer
The European Medicines Agency has recently released their positive opinion of ALUNBRIG, which is a treatment for anaplastic lymphoma kinase+ (ALK+) non-small cell lung cancer
Could This Investigational Drug be the Latest Advancement for Cholangiocarcinoma?
According to a story from curetoday.com, Dr. Tara Seery is an investigator in a phase 3 trial called PROOF, and she has just one goal:
New Designations for Infigratinib, a Treatment for Cholangiocarcinoma
BridgeBio Pharmaceuticals has recently announced that their drug, infigratinib, has received the Fast Track and Orphan Drug designations from the FDA. This drug is
-300x300.jpg)
A New Approach to Halting Metastatic Cancer
A recent article in Northwestern’s University Health reported that although the survival rate for cancer patients has vastly improved over the past twenty years, the
-300x170.png)
ICYMI: With the FDA’s Third Approval for Tissue Agnostic Therapies, Oncologists are Headed to the Next Level in Cancer Treatment
Since the 1940s oncologists have been focusing on tumors at the location in the body where the tumors originated. According to a recent FDA press
